BRIMONIDINE Labatec gtt opht 2 mg/ml fl 5 ml
7680685270016
CH-68527
S01EA05
1 / 3
google
Details
- GTIN
- 7680685270016
- Pharmacode
- -
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Brimonidine Labatec 2 mg/ml, collyre en solution
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
brimonidini tartras
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
brimonidinum
|
1.3 MG | Substance | Wirkstoff (Principe actif) |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
benzalkonii chloridum
|
50.0 UG | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 68527
- Drug name
- Brimonidine Labatec 2 mg/ml, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01EA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/01/2023
- Authorization expiration date
- 17/01/2028
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BRIMONIDINE Labatec gtt opht 2 mg/ml fl 5 ml
- Description (DE)
- BRIMONIDINE Labatec Gtt Opht 2 mg/ml Fl 5 ml
- Market launch
- 18/01/2023
- Narcotic (BTM)
- No